-
Report details
-
4
Figures
-
8
Tables
-
Chapter 1: Executive Summary
-
Chapter 2: Introduction
-
Introduction
-
Applications
-
Infectious Disease
-
Understanding Cancer with miRNAs
-
Atherosclerosis Research
-
Neurological
-
Market Trends
-
Increasing Numbers of Cells Analyzed
-
Significant Interest in Multi-omics
-
Spatial Transcriptomics, In Situ Techniques Gaining Traction
-
Data Analysis, Data Volumes, High Dimensionality Challenging
-
Convergence of Technological Advances
-
Litigation With Most Major Companies
-
Deals, Collaborations
-
Chapter 3: Market Analysis
-
Revenues Forecast
-
Regional Shares
-
Competitive Analysis
-
Products
-
Chapter 4: Company Profiles
-
10x Genomics
-
Bio-Rad
-
Dolomite Bio
-
Fluidigm
-
Illumina
-
Mission Bio
-
Qiagen
-
Takara Bio
|
Single Cell Analysis in Next-Generation Sequencing Markets (Market Size and Forecast, Segment Breakouts, Secondary Research), 2022-2027
5 May 2022
Single Cell Analysis in Next-Generation Sequencing Markets (Market Size and Forecast, Segment Breakouts, Secondary Research), 2022-2027 focuses on the market for single cell genomics products -- the hardware, service of the hardware, software, and consumables including for the sequencing step and other types of downstream analysis. It discusses trends, challenges, strategies, companies, and products, and provides estimates of market share and revenue growth for the market. The competitive situation, deals, and products are covered in respective chapters. Historical data for 2021 is provided, with forecast data spanning 2022-2027.
The provides the most current market research into single cell genomics and the companies that participate in this market. Some of the key market trends covered in the report include the following:
- Increasing number of cells profiled
- Multi-omics focus, products
- Spatial / in situ genomics, transcriptomics
- Data analysis challenges; software and IT introductions
- Convergence of technological advances
- Litigation
Companies Profiled include:
- 10X Genomics
- Bio-Rad
- Dolomite Bio
- Fluidigm
- Illumina
- Mission Bio
- Qiagen
- Takara Bio
Page Count: 45
Table of Contents
-
Chapter 1: Executive Summary
-
Chapter 2: Introduction
-
Introduction
-
Applications
-
Infectious Disease
-
Understanding Cancer with miRNAs
-
Atherosclerosis Research
-
Neurological
-
Market Trends
-
Increasing Numbers of Cells Analyzed
-
Significant Interest in Multi-omics
-
Spatial Transcriptomics, In Situ Techniques Gaining Traction
-
Data Analysis, Data Volumes, High Dimensionality Challenging
-
Convergence of Technological Advances
-
Litigation With Most Major Companies
-
Deals, Collaborations
-
Chapter 3: Market Analysis
-
Revenues Forecast
-
Regional Shares
-
Competitive Analysis
-
Products
-
Chapter 4: Company Profiles
-
10x Genomics
-
Bio-Rad
-
Dolomite Bio
-
Fluidigm
-
Illumina
-
Mission Bio
-
Qiagen
-
Takara Bio
|
More information about this product
Other Users Also Viewed
25 Aug 2021
21-050
Kalorama Information’s latest edition of our in vitro diagnostic market report represents the fourteenth time in two decades our analysts have fully assessed the in vitro diagnostic market from scratch and re-report numbers. Last year,…
|
